Genor Biopharma Holdings Ltd. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
No of Months
12
12
12
12
12
12
Profit Before Tax
538.00
523.00
-748.00
-851.00
-1,044.00
-3,411.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
-402.00
-9.00
-6.00
90.00
34.00
-242.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
286.00
716.00
-469.00
-675.00
-752.00
-881.00
Cash Flow from Investing Activities
910.00
-216.00
6.00
-15.00
-65.00
-110.00
Cash Flow from Financing Activities
-598.00
-462.00
-7.00
-65.00
22.00
4,200.00
Net Cash Inflow / Outflow
594.00
43.00
-467.00
-713.00
-878.00
3,009.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
-4.00
5.00
3.00
41.00
-82.00
-199.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in HKD Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Genor Biopharma Holdings Ltd.
Figures in Million
consolidated Cash Flow Results
Change(HKD)
Change(%)
Profit Before Tax
538.212075095034
-598.900918397302
1,136.00
189.87%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
-402.493735959434
68.0592641296984
-470.00
-691.39%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
286.673147106483
-94.3166594582636
380.00
403.95%
Cash Flow from Investing Activities
910.890094546562
-1.61377077563527
911.00
56544.83%
Cash Flow from Financing Activities
-598.472531665866
-173.19295968755
-425.00
-245.55%
Net Cash Inflow / Outflow
594.194086968366
-275.8040538851
869.00
315.44%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
-4.89662301881265
-6.68066396365137
2.00
26.70%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'25
YoY Growth in year ended Dec 2025 is -60.01% vs 252.59% in Dec 2024
Dec'25
Dec'24
Change(%)
Cash Flow from Operating Activities
286.67
716.81
-60.01%






